Research discovery

Find the original research

Live search across PubMed, the U.S. National Library of Medicine's citation database, and ClinicalTrials.gov. We show what each record is and link you to it; we don't summarise findings or rank studies by what they conclude.

Published studies · PubMed Clinical trials · ClinicalTrials.gov

Find the original research

Study of SC-102 in Patients With Advanced Solid Tumors (opens ClinicalTrials.gov)

A Clinical Study of MK-7962 in Chinese Participants With Pulmonary Arterial Hypertension (MK-7962-022) (opens ClinicalTrials.gov)

Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer (opens ClinicalTrials.gov)

Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV Melanoma (opens ClinicalTrials.gov)

A Clinical Trial Testing the Safety of the Investigational Drug Pumitamig (BNT327) and How Well it Works in Patients With Recurrent Glioblastoma (opens ClinicalTrials.gov)

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread (opens ClinicalTrials.gov)

FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer (opens ClinicalTrials.gov)

AI-Driven Metabolic Cohort in Overweight/Obese Chinese Adults (opens ClinicalTrials.gov)

Rebamipide Versus Diquafosol and Cyclosporine for Perioperative Dry Eye in Cataract Surgery (opens ClinicalTrials.gov)

A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer (opens ClinicalTrials.gov)

Immune Checkpoint Inhibitor Nivolumab in People With Recurrent Select Rare CNS Cancers (opens ClinicalTrials.gov)

ASKC202 Plus Limertinib as the First-line Therapy for Patients With EGFRm+/MET+ Locally Advanced or Metastatic NSCLC (opens ClinicalTrials.gov)

HS-IT101 Injection Versus Chemotherapy in the Treatment of Advanced Melanoma（FASTIL-Mela02） (opens ClinicalTrials.gov)

Toripalimab Plus Cetuximab and Irinotecan for Second-Line Right-Sided RAS/BRAF Wild-Type Advanced Colon Cancer Phase II Study (opens ClinicalTrials.gov)

Testing the Addition of an Anti-cancer Drug, Copanlisib, to the Usual Immunotherapy (Nivolumab With or Without Ipilimumab) in Patients With Advanced Solid Cancers That Have Changes in the Following Genes: PIK3CA and PTEN (opens ClinicalTrials.gov)

An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) (opens ClinicalTrials.gov)

Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study (opens ClinicalTrials.gov)

A Study of SHR-A1811 Combined With Adebrelimab for the First-line HER2-overexpressing Non-squamous Non-small Cell Lung Cancer (opens ClinicalTrials.gov)

Testing the Addition of Atezolizumab to Combination Chemotherapy or Atezolizumab Alone for Metastatic Colon or Rectal Cancer, the COMMIT Study (opens ClinicalTrials.gov)

Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma (opens ClinicalTrials.gov)